Literature DB >> 9500316

Prediction of death and myocardial infarction by screening with exercise-thallium testing after coronary-artery-bypass grafting.

M S Lauer1, B Lytle, F Pashkow, C E Snader, T H Marwick.   

Abstract

BACKGROUND: The role of myocardial-perfusion imaging in calculating risk in symptom-free patients who have had coronary-artery-bypass grafting (CABG) is unclear. Practice guidelines have argued against routine screening of these patients. We sought to find out the independent and incremental prognostic value of exercise thallium-201 single-photon-emission computed tomography (SPECT) for prediction of death and non-fatal myocardial infarction (MI) in these patients.
METHODS: Analyses were based on 873 symptom-free patients undergoing symptom-limited exercise thallium-201 SPECT between September, 1990, and December, 1993. All had undergone CABG and none had recurrent angina or other major intercurrent coronary events. Exercise and thallium-perfusion variables were analysed to determine their prognostic importance during 3 years of follow-up.
FINDINGS: Myocardial-perfusion defects were noted in 508 (58%) patients. There were 57 deaths and 72 patients had major events (death or non-fatal MI). Patients with thallium-perfusion defects were more likely to die (9% vs 3%, p=0.0004) or suffer a major event (11% vs 4%, p=0.0002). Reversible defects were also predictive of death (12% vs 5%, p=0.002) and major events (13% vs 7%, p=0.004). The exercise variable with the strongest predictive power was an impaired (< or = 6 METs [measure of oxygen consumption equal to 3.5 mL/kg/min]) exercise capacity; poor exercise capacity was predictive of death (18% vs 4%, p<0.0001) and death or non-fatal MI (19% vs 5%, p<.00001). After adjusting for baseline clinical variables, surgical variables, time elapsed since CABG, and standard cardiovascular risk factors, thallium-perfusion defects remained predictive of death (adjusted relative risk 2.78, 95% CI 1.44-5.39) and major events (2.63, 1.49-4.66). Similarly, impaired exercise remained strongly predictive of death (4.16, 2.38-7.29) and major events (3.61, 2.22-5.87) after adjusting for confounders.
INTERPRETATION: In this group of patients who were symptom-free after CABG, thallium-perfusion defects and impaired exercise capacity were strong and independent predictors of subsequent death or non-fatal MI. Recommendations against routine screening exercise myocardial-perfusion studies in this setting should be reconsidered.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9500316     DOI: 10.1016/S0140-6736(97)07062-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  32 in total

1.  Proceedings of the 4th Invitational Wintergreen Conference. Wintergreen, Virginia, USA. July 12-14, 1998. Abstracts.

Authors: 
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

2.  Role of myocardial perfusion imaging after coronary revascularization in symptom-free patients: are low-risk patients really low?

Authors:  Dominick Joseph Angiolillo; Alessandro Giordano
Journal:  J Nucl Cardiol       Date:  2002 Sep-Oct       Impact factor: 5.952

Review 3.  Assessment of prognosis in chronic coronary artery disease.

Authors:  T M Bateman; E Prvulovich
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

Review 4.  Prognostic value of gated myocardial perfusion SPECT.

Authors:  Leslee J Shaw; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

5.  The role of radionuclide myocardial perfusion imaging for asymptomatic individuals.

Authors:  Robert C Hendel; Brian G Abbott; Timothy M Bateman; Ron Blankstein; Dennis A Calnon; Jeffrey A Leppo; Jamshid Maddahi; Matthew M Schumaecker; Leslee J Shaw; R Parker Ward; David G Wolinsky
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

6.  Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424.

Authors:  Leslee J Shaw; Gary V Heller; Paul Casperson; Romalisa Miranda-Peats; Piotr Slomka; John Friedman; Sean W Hayes; Ronald Schwartz; William S Weintraub; David J Maron; Marcin Dada; Spencer King; Koon Teo; Pamela Hartigan; William E Boden; Robert A O'Rourke; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2006-09       Impact factor: 5.952

Review 7.  Role of nuclear imaging after coronary revascularization.

Authors:  George L Adams; Srivani R Ambati; John M Adams; Salvador Borges-Neto
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

8.  American Society of Nuclear Cardiology review of the ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI).

Authors:  R Parker Ward; Mouaz H Al-Mallah; Gabriel B Grossman; Christopher L Hansen; Robert C Hendel; Todd C Kerwin; Benjamin D McCallister; Rupa Mehta; Donna M Polk; Peter L Tilkemeier; Aseem Vashist; Kim Allan Williams; David G Wolinsky; Edward P Ficaro
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

9.  Long-term effects of a multimodal behavioral intervention on myocardial perfusion--a randomized controlled trial.

Authors:  Christian Albus; Peter Theissen; Martin Hellmich; Reinhard Griebenow; Beate Wilhelm; Demet Aslim; Harald Schicha; Karl Köhle
Journal:  Int J Behav Med       Date:  2009-05-08

10.  Myocardial perfusion imaging in patients with a recent, normal exercise test.

Authors:  Ann Bovin; Ib C Klausen; Lars J Petersen
Journal:  World J Cardiol       Date:  2013-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.